简介内容:PBI-6DNJ, an orally active and potent multivalent glycosidase inhibitor, demonstrates significant inhibition activity against α-glucosidase from mice, featuring a K i value of μM. It also exhibits notable hypoglycemic activity, making it suitable for type 2 diabetes research [1].